Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders

Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases

(2011) Markus A. Rüegg et al.   Annual Review of Pharmacology and Toxicology

Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population

(2011) Guido Stadler et al.   Skeletal Muscle

TGF-β1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation

(2010) Shouli Wang et al.   CANCER SCIENCE

Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin–proteasome pathway

(2010) Alban Vignaud et al.   NEUROMUSCULAR DISORDERS

Large CTG Repeats Trigger p16-Dependent Premature Senescence in Myotonic Dystrophy Type 1 Muscle Precursor Cells

(2009) Anne Bigot et al.   AMERICAN JOURNAL OF PATHOLOGY

Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects

(2009) Umbertina Conti Reed   ARQUIVOS DE NEURO-PSIQUIATRIA

Gene therapy for muscular dystrophy: current progress and future prospects

(2009) Capucine Trollet et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in Duchenne Muscular Dystrophy Cells

(2009) Soraya Chaouch et al.   HUMAN GENE THERAPY

In Vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A Quantitative Study

(2009) Elisa Negroni et al.   MOLECULAR THERAPY

Replicative aging down-regulates the myogenic regulatory factors in human myoblasts

(2008) Anne Bigot et al.   BIOLOGY OF THE CELL

Facioscapulohumeral muscular dystrophy

(2008) Rabi Tawil   Neurotherapeutics